Sclerostin Activators
Sclerostin Activators constitute a class of chemical compounds that play a significant role in regulating the activity of the protein known as sclerostin. Sclerostin is a secreted glycoprotein primarily produced by osteocytes, specialized bone cells found within the mineralized bone matrix. It is known for its pivotal role in the regulation of bone metabolism and the modulation of bone mass. Sclerostin functions as a negative regulator of bone formation, primarily by inhibiting the Wnt/β-catenin signaling pathway, which is a critical pathway involved in bone development and remodeling. Sclerostin Activators are small molecules designed to interact with sclerostin, modulating its activity and influencing bone homeostasis and remodeling.
The mechanism of action of Sclerostin Activators typically involves binding to specific regions of the sclerostin protein, inducing conformational changes that can alter its interactions with Wnt signaling components. By modulating sclerostin activity, these activators can impact the inhibition of the Wnt/β-catenin pathway, which, in turn, may have implications for bone formation, resorption, and overall bone health. Research into Sclerostin Activators provides valuable insights into the complex regulatory mechanisms governing bone metabolism and the role of sclerostin in maintaining bone mass. Understanding how these activators interact with sclerostin contributes to our knowledge of the intricate balance between bone formation and resorption.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol has been shown to modulate Sclerostin levels. It can indirectly increase Sclerostin expression through its action on estrogen receptors in bone tissue, influencing bone remodeling and Sclerostin expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone can increase Sclerostin expression in bone cells. It is a glucocorticoid that influences various metabolic processes, including bone metabolism, and its use has been associated with increased Sclerostin levels, leading to reduced bone formation. | ||||||
Parathyroid hormone fragment (1-34) | 52232-67-4 | sc-487943 | 100 µg | $185.00 | ||
Intermittent administration of Parathyroid Hormone can initially decrease but subsequently increase Sclerostin expression. PTH has a complex role in bone metabolism, and its effects on Sclerostin are part of the regulatory mechanisms in bone remodeling. | ||||||
Sodium Fluoride | 7681-49-4 | sc-24988A sc-24988 sc-24988B | 5 g 100 g 500 g | $40.00 $46.00 $100.00 | 26 | |
Fluoride, at high concentrations, can increase Sclerostin expression. It is known for its role in dental and bone health, but excessive fluoride exposure is associated with changes in bone metabolism, including increased Sclerostin expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid, found in Vitamin A, influences bone metabolism and has been shown to affect Sclerostin expression. It acts on retinoic acid receptors and can modulate bone cell activity, including Sclerostin expression in osteocytes. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2, a lipid compound, can influence bone metabolism and Sclerostin expression. It acts through prostaglandin receptors and has various roles in bone remodeling, including potential effects on Sclerostin levels. | ||||||